JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

Search

Treace Medical Concepts Inc

Closed

2.27 -1.73

Overview

Share price change

24h

Current

Min

2.25

Max

2.35

Key metrics

By Trading Economics

Income

1.1M

-16M

Sales

2.8M

50M

Profit margin

-32.437

Employees

477

EBITDA

1.3M

-12M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+130.17% upside

Dividends

By Dow Jones

Next Earnings

26 lut 2026

Market Stats

By TradingEconomics

Market Cap

-257M

159M

Previous open

4

Previous close

2.27

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Treace Medical Concepts Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 lut 2026, 23:52 UTC

Acquisitions, Mergers, Takeovers

Elliott Management Doesn't Plan to Tender Its Shares at the Current Terms

2 lut 2026, 23:52 UTC

Acquisitions, Mergers, Takeovers

Elliott Management: Toyota Fudosan Revised Tender Offer for Toyota Industries 'Very Significantly Undervalues' Company

2 lut 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Signs of U.S. Economic Strength -- Market Talk

2 lut 2026, 23:38 UTC

Market Talk

Gold Rises on Likely Technical Recovery, Dip-Buying Interest -- Market Talk

2 lut 2026, 23:28 UTC

Market Talk

SpaceX, xAI Deal Further Consolidates Musk's Businesses -- Market Talk

2 lut 2026, 23:23 UTC

Earnings

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- 2nd Update

2 lut 2026, 22:57 UTC

Earnings

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 lut 2026, 22:22 UTC

Acquisitions, Mergers, Takeovers

What the Blockbuster SpaceX--xAI Merger Can Mean for Tesla Stock -- Barrons.com

2 lut 2026, 22:08 UTC

Market Talk

Australian Inflation Woes Rooted In Excess Govt Spending -- Market Talk

2 lut 2026, 21:51 UTC

Earnings

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 lut 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2 lut 2026, 21:49 UTC

Earnings

Disney's Streaming Profit Surges as CEO Decision Approaches -- 5th Update

2 lut 2026, 21:39 UTC

Earnings

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 lut 2026, 21:36 UTC

Earnings

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- Update

2 lut 2026, 21:34 UTC

Earnings

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 lut 2026, 21:28 UTC

Acquisitions, Mergers, Takeovers

What a SpaceX--xAI Merger Could Mean for Tesla Stock -- Barrons.com

2 lut 2026, 21:23 UTC

Earnings

BYD, Chinese EV Stock Plunge On Weak Data. What That Means for Tesla Stock. -- Barrons.com

2 lut 2026, 21:19 UTC

Earnings

Palantir Technologies: U.S. Commercial Business Growing at 'Astonishing' Rate, Generating $507 Million Last Quarter, 137% Increase Over the Same Period the Year Before >PLTR

2 lut 2026, 21:17 UTC

Earnings

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- WSJ

2 lut 2026, 21:17 UTC

Earnings

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 lut 2026, 21:10 UTC

Earnings

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 lut 2026, 21:08 UTC

Earnings

Palantir Technologies: Rule of 40 Score Is Now 127% >PLTR

2 lut 2026, 21:07 UTC

Earnings

Palantir Technologies: Sees 2026 U.S. Comml Rev in Excess of $3.144B, Representing Growth Rate of at Least 115% >PLTR

2 lut 2026, 21:05 UTC

Earnings

Palantir Technologies 4Q Net $608.7M >PLTR

2 lut 2026, 21:05 UTC

Earnings

Palantir Technologies 4Q Rev $1.41B >PLTR

2 lut 2026, 21:05 UTC

Earnings

Palantir Technologies Sees 1Q Rev $1.53B-$1.54B >PLTR

2 lut 2026, 21:05 UTC

Earnings

Palantir Technologies Sees FY Rev $7.18B-$7.2B >PLTR

2 lut 2026, 21:05 UTC

Earnings

Palantir Technologies 4Q Adj EPS 25c >PLTR

2 lut 2026, 21:05 UTC

Earnings

Palantir Technologies 4Q EPS 24c >PLTR

2 lut 2026, 20:40 UTC

Market Talk

Treasury Yields, Dollar Rise Amid Signs of Resilient U.S. Economy -- Market Talk

Peer Comparison

Price change

Treace Medical Concepts Inc Forecast

Price Target

By TipRanks

130.17% upside

12 Months Forecast

Average 5.34 USD  130.17%

High 7.5 USD

Low 3 USD

Based on 6 Wall Street analysts offering 12 month price targets forTreace Medical Concepts Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

6 ratings

1

Buy

4

Hold

1

Sell

Technical Score

By Trading Central

7.16 / 7.65Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bullish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
help-icon Live chat